KWKR advised NCBR Investment Fund during its co-investment in IMAGENE.ME

KWKR Law Firm advised NCBR Investment Fund ASI S.A. in its co-investment in IMAGENE.ME, an innovative Polish biotechnology company operating in the field of personal genomics. The transaction, worth PLN 6 million, was carried out by our client in cooperation with the ABAN.VC fund.

Our legal team provided comprehensive support for the transaction, which included activities from assessing the results of due diligence to determining the content of the investment agreement.

Once again, our law firm played an important role in the successful execution of complex investment transactions, supporting innovative Polish companies on their way to international success. The transaction was overseen by Paulina Opiełka, partner at KWKR, and led by our associates Paweł Machowski and Dominik Korybalski.

IMAGENE.ME is a pioneer in the field of advanced genetic diagnostics, personalised preventive healthcare and innovative solutions in personal genomics. The investment will enable the company to expand dynamically into international markets and strengthen its leadership position in the European genomics sector.

In the transaction process, the ABAN.VC fund was supported by a team of lawyers, consisting of experts from TRILOKA Intellectual Property Office and attorneys Damian Grzegorczyk, Marta Szymczak-Kozłowska and Konrad Trzyna.